The appeals court will soon investigate safety concerns around the use of mifepristone, a still-approved FDA drug that has been an option for abortion procedures for nearly 20 years. Despite recent controversy over the regulation of mifepristone, clinicians and experts argue that it is far less risky than full-term pregnancy when guidelines are followed properly; the Supreme Court has yet to announce how they will address concerns over its use.